DeutschNewstral
Article
bizjournals.com on 2018-05-29 14:40
As GSK broadens respiratory portfolio, Triangle at the center
Related news
GSK awards IMPACT grants to Triangle nonprofitsnewsobserver.com- GSK gives $400,000 to Triangle nonprofitsbizjournals.com
- FGSK hopes for boost from respiratory virus jabft.com
GSK hails potential respiratory virus jab after trial resultsFinancial Times- FGSK PLC: GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bnft.com
- The role of respiratory drugs in GSK's treatment portfoliobizjournals.com
- Nonprofit News: GSK awards Triangle housing, literacy nonprofits $50,000 eachbizjournals.com
- GSK layoffs focused on PA and U.K. sites – not Trianglebizjournals.com
- How a GSK spinoff might affect the Triangle – if it happensbizjournals.com
- GSK to slash Triangle footprint by nearly 90% with move to downtown Durhambizjournals.com
- Elliott Management Corp: Elliott portfolio manager behind GSK and Freseni campaigns leaves firmFinancial Times
- GSK chooses Maryland for new vaccine R&D centerbizjournals.com
- Center for Breakthrough Medicines adds former GSK, Janssen exec to leadership teambizjournals.com
- California REIT adds to Triangle portfolio with $40M buy for distribution center in Garnerbizjournals.com
Mylan acquisiton broadens women’s health care portfolioobserver-reporter.com
Ngāi Te Rangi broadens its portfolioNZ Herald- Subway franchisee broadens portfolio with Saratoga apartment projectbizjournals.com
Norman Pointe I purchase broadens REIT’s local portfoliofinance-commerce.com- GSK sells RTP campusbizjournals.com
- Draper Triangle portfolio company sells for $93Mbizjournals.com